Previous Close | 1.4500 |
Open | 1.4300 |
Bid | 1.4200 x 600 |
Ask | 1.4500 x 600 |
Day's Range | 1.4200 - 1.4700 |
52 Week Range | 0.8400 - 1.8800 |
Volume | |
Avg. Volume | 1,155,849 |
Market Cap | 354.71M |
Beta (5Y Monthly) | 1.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3900 |
Earnings Date | May 08, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for PGEN
Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript March 19, 2024 Precigen, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.08. PGEN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the […]
Challenges Persist as Total Revenues Decline by 76.9% Year-Over-Year
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced full year 2023 financial results and business updates.